Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS

12 Months Ended

Dec. 31, 2019

NOTE 5—SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS

Inventories consisted of the following (in thousands):

	As of December 31,
Inventories by category	2019		2018
Raw materials and components	$	1,145	$	171
Work-in-process		2,187		2,471
Finished goods		4,639		2,063
Total	$	7,971	$	4,705

Prepaid expenses and other current assets consisted of the following (in thousands):

	As of December 31,
	2019		2018 (As Restated)
Prepaid insurance	$	735	$	223
Other prepaid expenses and current assets		667		411
	$	1,402	$	634

Property and equipment consisted of the following (in thousands):

	As of December 31,
	2019			2018
Equipment	$	335		$	306
Leasehold improvements		77			70
Furniture and fixtures		95			79
Total property and equipment		507			455
Less: accumulated depreciation		(356	)		(303	)
Property and Equipment, net	$	151		$	152

During the years ended December 31, 2019 and 2018, depreciation expenses were approximately $59,000 and $47,000, respectively.